Mastering the complexities of targeted medicines
White paper
Download now
This white paper presents
considerations for planning,
developing, and bringing to
market targeted medicines with
specific considerations for
organizations to contemplate
across key domains.
Key
learning objectives:
- Understanding the regulatory landscape for targeted medicines
- Learning how biomarkers are used in treatment with a targeted therapy
- Discovering why companion diagnostics (CDx) are an indispensable tool in the field of targeted therapies
- Developing strategies to navigate the complexities of developing targeted medicines
